Regd. Office: First Floor, 12, Sant Nagar, East of Kailash, New Delhi - 110 065

                   AUDITED FINANCIAL RESULTS  FOR THE YEAR ENDED 31ST MARCH, 2007

(Rs. in lacs)

Sr. No.

Particulars

Nine months Ended

Quarter Ended

Year Ended

31st December

31st March

31st March

2006

2007

2006

2007

2006

(Reviewed)

(Unaudited)

(Audited)

(Audited)

1

Gross Sales/Income from operations

6387.47

2323.51

2025.53

8710.98

7156.00

Less-Excise Duty

148.61

72.69

11.28

221.30

106.49

Net Sales/Income from operations

6238.86

2250.82

2014.25

8489.68

7049.51

2

Other Income

2.37

25.96

(19.51)

28.33

50.45

Total Income

6241.23

2276.78

1994.74

8518.01

7099.96

3

Total Expenditure

5087.23

1780.06

1530.00

6867.29

5724.09

a. (Increase)/Decrease in stock in trade

(150.01)

53.42

95.25

(96.59)

36.22

b. Consumption of Raw materials

2926.17

1028.33

795.41

3954.50

3219.40

c. Staff Cost

875.50

264.98

263.09

1140.48

947.10

d. Other Expenditure

1435.57

433.33

376.25

1868.90

1521.37

4

Profit before Depreciation, Interest & taxes

1154.00

496.72

464.74

1650.72

1375.87

5

Interest & Finance Charges

143.22

85.68

47.12

228.90

184.21

6

Depreciation

270.14

121.57

96.58

391.71

340.04

7

Profit before tax

740.64

289.47

321.04

1030.11

851.62

8

Provision for Taxation

    -Current Tax

136.33

29.67

25.37

166.00

118.00

    -Prior Period Tax

(15.30)

(1.66)

(15.30)

(1.66)

    -Deferred Tax

10.09

34.46

6.00

44.55

9.90

    -Fringe Benefits  Tax

5.65

2.15

4.90

7.80

7.85

9

Net Profit

588.57

238.49

286.43

827.06

717.53

11

Reserves excluding Revaluation Reserve

2914.85

2245.73

12

Earning Per Share-Basic (Rs.)

10.90

4.42

5.30

15.32

13.29

Earning Per Share-Diluted (Rs.)

10.90

4.37

5.30

15.27

13.29

13

Aggregate of non-promoter Shareholding

    -No. of Shares

2870704

2881704

2870704

2881704

2870704

    -Percentage of Shareholding

53.16%

53.36%

53.16%

53.36%

53.16%

Notes:

1. The  Company is primarily engaged in a business of manufacture and sale of "Medical Disposables" and, hence, there is no reportable segments as  per Accounting Standard-17 issued by ICAI.

2. The New project at Hardwar is now scheduled to commence commercial production during the quarter ended June, 2007.

3. The Board of Directors have recommended a dividend  @ 25% ( Rs.2.50 Per equity shares of Rs. 10/- each) for the F.Y.2006-07.

4. The Board of Directotrs vide their meeting dated 17th March,2007 allotted 425000 Convertible Preferential Warrants to the Promoters group in terms of Shareholders Resolution passed in 11th AGM held on 5th September, 2006 and SEBI Preferential Issue Guidelines.

5. The Company did not receive any Investor Complaints during this quarter and their was no pending complaint either at the beginning or end of the quarter.

6. The above  results have  been  reviewed  by the  Audit Committee and taken on record by the Board of Directors in their meeting held on 26th May,2007.

7. The previous period's figures have been regrouped/recasted, wherever necessary to make them comparable with the current period's figures.

      By order of the Board

 Place : New Delhi

                 Himanshu Baid

 Date  : 26.05.2007

           Managing Director